Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction

BACKGROUND: Soluble suppression of tumorigenicity 2 (sST2) receptor is a biomarker that is elevated in certain systemic inflammatory diseases. Comorbidity‐driven microvascular inflammation is postulated to play a key role in heart failure with preserved ejection fraction (HFpEF) pathophysiology, but...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: AbouEzzeddine, Omar F., McKie, Paul M., Dunlay, Shannon M., Stevens, Susanna R., Felker, G. Michael, Borlaug, Barry A., Chen, Horng H., Tracy, Russell P., Braunwald, Eugene, Redfield, Margaret M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523750/
https://ncbi.nlm.nih.gov/pubmed/28214792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.004382
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars